Integrated Nanotherapeutics Inc.
Natalie Dakers is an accomplished professional with extensive experience in health sciences, technology commercialization, and entrepreneurship. Currently serving as a board member at Pender Private Investments Inc., LifeLabs Medical Laboratory Services, and STEMCELL Technologies, Dakers has played key roles in various organizations since 1997, including founding and leading Neuromed Technologies Inc., The Centre for Drug Research and Development (CDRD), and CDRD Ventures Inc. As the Adjunct Professor at The University of British Columbia, Dakers continues to contribute to the academic field. With a Bachelor of Science in Marine Biology from The University of Guelph, Natalie Dakers has a proven track record of raising significant capital and fostering innovation within the health sciences sector.
This person is not in the org chart
This person is not in any teams
Integrated Nanotherapeutics Inc.
Integrated Nanotherapeutics Inc. is a biopharmaceutical company dedicated to the development of novel drugs in the areas of cancer and autoimmunity, including diabetes, where there is significant unmet medical need for therapeutic agents with improved activity. Our proprietary technologies allow the incorporation of any compound in lipid nanoparticle delivery systems and thus extend the benefits of delivery systems to virtually any therapeutic and diagnostic agent. We envision that many existing drugs or agents can be made much safer and more effective using our technologies.